Literature DB >> 2685121

Suppression of MHC class I RNA in highly oncogenic cells occurs at the level of transcription initiation.

N Lassam1, G Jay.   

Abstract

The oncogenic potential of some transformed cell lines has been shown in animal tumor models to be the direct result of MHC class I mRNA suppression. Rodent cells established with the highly oncogenic human adenovirus type 12 exhibit greatly reduced levels of class I Ag compared with cells derived with the nononcogenic adenovirus type 5. By using seven independently derived adenovirus-transformed cell lines, we have investigated the mechanism responsible for down-regulation of class I RNA expression. In all adenovirus 12-transformed cells examined, class I RNA suppression was the result of a block in transcription initiation. Highly oncogenic cell lines derived from a spontaneous melanoma and a chemically induced sarcoma also showed greatly reduced transcription of class I genes. We conclude that suppression of MHC class I RNA in a variety of highly oncogenic cells results largely from a substantial decrease in transcription initiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2685121

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Impairment of MHC class I transcription in a mutant bovine B cell line.

Authors:  J S Harms; G A Splitter
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  An HLA-B regulatory element binds a factor immunologically related to the upstream stimulation factor.

Authors:  J Girdlestone
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

3.  Inducible heat shock protein 70 expression as a potential predictive marker of metastasis in breast tumors.

Authors:  Carolina Torronteguy; Antonio Frasson; Felipe Zerwes; Erik Winnikov; Vinicius Duval da Silva; Antoine Ménoret; Cristina Bonorino
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

4.  Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.

Authors:  L T Peltenburg; P I Schrier
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

5.  Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response.

Authors:  N P Restifo; F Esquivel; A L Asher; H Stötter; R J Barth; J R Bennink; J J Mulé; J W Yewdell; S A Rosenberg
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

6.  Characterization of defectiveness in endogenous antigen presentation of novel murine cells established from methylcholanthrene-induced fibrosarcomas.

Authors:  K Kuroda; K Yamashina; N Kitatani; A Kagishima; T Hamaoka; Y Hosaka
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

7.  Adenovirus 12-mediated down-regulation of the major histocompatibility complex (MHC) class I promoter: identification of a negative regulatory element responsive to Ad12 E1A.

Authors:  J L Proffitt; E Sharma; G E Blair
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

8.  Identification of human cancers deficient in antigen processing.

Authors:  N P Restifo; F Esquivel; Y Kawakami; J W Yewdell; J J Mulé; S A Rosenberg; J R Bennink
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

9.  A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.

Authors:  N P Restifo; P J Spiess; S E Karp; J J Mulé; S A Rosenberg
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

10.  Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

Authors:  F V Cromme; J Airey; M T Heemels; H L Ploegh; P J Keating; P L Stern; C J Meijer; J M Walboomers
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.